A study on the utilization of canagliflozin in type 1 diabetes mellitus using real‐world data from four European countries

20250 citationsJournal Article

Authors

Real-world data analyses from four European countries showed that off-label use of canagliflozin for T1DM was rare.

Partnerships for the goals

Published in: Diabetes Obesity and Metabolism

Volume 27, Issue 9, pp. 5217-5224

Field-Weighted Citation Impact: 0.00